Your browser doesn't support javascript.
loading
Air pollution and COPD: GOLD 2023 committee report.
Sin, Don D; Doiron, Dany; Agusti, Alvar; Anzueto, Antonio; Barnes, Peter J; Celli, Bartolome R; Criner, Gerard J; Halpin, David; Han, MeiLan K; Martinez, Fernando J; Montes de Oca, Maria; Papi, Alberto; Pavord, Ian; Roche, Nicolas; Singh, Dave; Stockley, Robert; Lopez Varlera, M Victorina; Wedzicha, Jadwiga; Vogelmeier, Claus; Bourbeau, Jean.
Afiliação
  • Sin DD; Centre for Heart Lung Innovation, St Paul's Hospital and University of British Columbia Division of Respiratory Medicine, Vancouver, BC, Canada don.sin@hli.ubc.ca.
  • Doiron D; McGill University Health Centre, McGill University, Montreal, QC, Canada.
  • Agusti A; Respiratory Institute, Hospital Clinic, IDIBAPS, University of Barcelona and CIBERES, Barcelona, Spain.
  • Anzueto A; South Texas Veterans Health Care System, University of Texas, San Antonio, TX, USA.
  • Barnes PJ; National Heart and Lung Institute, Imperial College London, London, UK.
  • Celli BR; Harvard Medical School, Boston, MA, USA.
  • Criner GJ; Temple University School of Medicine, Philadelphia, PA, USA.
  • Halpin D; University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.
  • Han MK; University of Michigan, Ann Arbor, MI, USA.
  • Martinez FJ; Weill Cornell Medical Center/New York-Presbyterian Hospital, New York, NY, USA.
  • Montes de Oca M; Hospital Universitario de Caracas, Universidad Central de Venezuela, Centro Médico de Caracas, Caracas, Venezuela.
  • Papi A; Respiratory Medicine, University of Ferrara, Ferrara, Italy.
  • Pavord I; Respiratory Medicine Unit and Oxford Respiratory NIHR Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Roche N; Service de Pneumologie, Hôpital Cochin, AP-HP, Université Paris Cité, UMR 1016, Institut Cochin, Paris, France.
  • Singh D; University of Manchester, Manchester, UK.
  • Stockley R; University Hospital, Birmingham, UK.
  • Lopez Varlera MV; Universidad de la República, Hospital Maciel, Montevideo, Uruguay.
  • Wedzicha J; National Heart and Lung Institute, Imperial College London, London, UK.
  • Vogelmeier C; Department of Medicine, Pulmonary and Critical Care Medicine, University Hospital Giessen and Marburg, German Center for Lung Research (DZL), University of Marburg, Marburg, Germany.
  • Bourbeau J; McGill University Health Centre, McGill University, Montreal, QC, Canada.
Eur Respir J ; 61(5)2023 05.
Article em En | MEDLINE | ID: mdl-36958741
ABSTRACT
Exposure to air pollution is a major contributor to the pathogenesis of COPD worldwide. Indeed, most recent estimates suggest that 50% of the total attributable risk of COPD may be related to air pollution. In response, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Scientific Committee performed a comprehensive review on this topic, qualitatively synthesised the evidence to date and proffered recommendations to mitigate the risk. The review found that both gaseous and particulate components of air pollution are likely contributors to COPD. There are no absolutely safe levels of ambient air pollution and the relationship between air pollution levels and respiratory events is supra-linear. Wildfires and extreme weather events such as heat waves, which are becoming more common owing to climate change, are major threats to COPD patients and acutely increase their risk of morbidity and mortality. Exposure to air pollution also impairs lung growth in children and as such may lead to developmental COPD. GOLD recommends strong public health policies around the world to reduce ambient air pollution and for implementation of public warning systems and advisories, including where possible the use of personalised apps, to alert patients when ambient air pollution levels exceed acceptable minimal thresholds. When household particulate content exceeds acceptable thresholds, patients should consider using air cleaners and filters where feasible. Air pollution is a major health threat to patients living with COPD and actions are urgently required to reduce the morbidity and mortality related to poor air quality around the world.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Poluentes Atmosféricos / Poluição do Ar Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Eur Respir J Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Poluentes Atmosféricos / Poluição do Ar Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Eur Respir J Ano de publicação: 2023 Tipo de documento: Article